Evidence map›Paper›PMID 38294222›Full record

ArticleMicrobiology spectrum2024

A prospective study of nanopore-targeted sequencing in the diagnosis of central nervous system infections.

Yu Fu, Jihong Gu, Liang-Jun Chen, Mengyuan Xiong, Jin Zhao, Xiao Xiao, Junying Zhou, Zhiqiang Li, Yirong Li

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Frontiers in medicine · 2026
    Article
  3. Enrichment techniques for clinical metagenomics.Frontiers in cellular and infection microbiology · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yu Fu *Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jihong Gu *Department of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.ORCID 0000-0001-9906-9478
Liang-Jun ChenDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Mengyuan XiongDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jin ZhaoDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Xiao XiaoDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Junying ZhouDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.
Zhiqiang LiDepartment of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China.ORCID 0000-0003-0144-8790
Yirong LiDepartment of Clinical Laboratory, Zhongnan Hospital of Wuhan University, Wuhan, China.ORCID 0000-0002-5619-1614
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central nervous system (CNS) infections are a leading cause of death in patients. Nanopore-targeted sequencing (NTS) has begun to be used for pathogenic microbial detection. This study aims to evaluate the ability of NTS in the detection of pathogens in cerebrospinal fluid (CSF) through a prospective study. Fifty CSF specimens collected from 50 patients with suspected CNS infections went through three methods including NTS, metagenomic next-generation sequencing (mNGS), and microbial culture in parallel. When there was an inconsistency between NTS results and the results of the mNGS, the 16S rDNA gene was amplified followed by Sanger sequencing to further verify pathogens detected by NTS. Among 50 CSF specimens, 76% were NTS-positive, which is lower than mNGS (94.0%), yet higher than microbial culture (16.0%). The overall validation rate, diagnostic accordance rate (DAR), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of NTS were 86.7%, 50.0%, 71.0%, 15.8%, 57.9%, and 25.0%, respectively. In the CSF total nucleated cell (TNC) number ≤10 cells/µL, DAR, specificity, and PPV were 20%, 11.1%, and 11.1%, whereas in that with CSF TNC number >10 cells/µL, DAR, sensitivity, specificity, PPV, and NPV were 57.5%, 70.0%, 20.0%, 72.4%, and 18.2%, respectively. Although NTS has a higher microbial detection rate than microbial culture, it should combine CSF TNC result to evaluate the value of NTS for the diagnosis of CNS infections. IMPORTANCE: This study aims to prospectively evaluate the ability of nanopore-targeted sequencing (NTS) in the detection of pathogens in cerebrospinal fluid (CSF). It was the first time combining mNGS and microbial culture to verify the NTS-positive results also using 16S rDNA amplification with Sanger sequencing. Although microbial culture was thought to be the gold standard for pathogens detection and diagnosis of infectious diseases, this study suggested that microbial culture of CSF is not the most appropriate way for diagnosing central nervous system (CNS) infection. NTS should be recommended to be used in CSF for diagnosing CNS infection. When evaluating the value of NTS for diagnosis of CNS infections, the results of CSF TNC should be combined, and NTS-positive result is observed to be more reliable in patients with CSF TNC level >10 cells/μL.

Indexed as

Central Nervous System InfectionsNanoporesDNA, RibosomalHigh-Throughput Nucleotide SequencingHumansMetagenomicsPredictive Value of TestsProspective StudiesDNA, Ribosomalcentral nervous system infectionsclinical indicatorsnanopore-targeted sequencing

Identifiers

PMID38294222
PMCPMC10913467
OpenAlexW4391403359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.